[The Advanced Breast Biopsy Instrumentation (ABBI) for evaluation of mammographically suspicious, non-palpable findings of the breast: a reliable diagnosis with minor therapeutic potential].

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Transliterated Title:
      Die Advanced Breast Biopsy Instrumentation (ABBI) für die Evaluation mammographisch verdächtiger, nicht-palpabler Befunde der Brustdrüse: Eine zuverlässige Diagnostik mit geringem therapeutischen Potential.
    • Source:
      Publisher: Verlag Hans Huber Country of Publication: Switzerland NLM ID: 9514313 Publication Model: Print Cited Medium: Print ISSN: 1023-9332 (Print) Linking ISSN: 10239332 NLM ISO Abbreviation: Swiss Surg Subsets: MEDLINE
    • Publication Information:
      Original Publication: Bern : Verlag Hans Huber, c1995-
    • Subject Terms:
      Mammography*; Biopsy/*instrumentation ; Breast Diseases/*pathology ; Breast Neoplasms/*pathology; Adult ; Aged ; Anesthesia, Local ; Breast/pathology ; Breast Diseases/diagnostic imaging ; Breast Neoplasms/diagnostic imaging ; Equipment Design ; Female ; Humans ; Middle Aged ; Sensitivity and Specificity
    • Abstract:
      Background: Stereotactic biopsy techniques supersede conventional hook-wire localization followed by open excision to clarify the dignity of nonpalpable mammographic lesions. The advanced breast biopsy instrumentation (ABBI) allows stereotactically guided excision of a specimen up to 20 mm in diameter on an outpatient basis under local anaesthesia.
      Methods: Demographic information, mammographic and pathological findings, complications, subsequent interventions and sensitivity as well as efficiency of a series of 144 planned ABBI procedures were documented (largest published single institution series).
      Results: The ABBI procedure was successfully performed in 93.8% (135/144); accurate diagnosis was made in 99.3% (134/135), sensitivity for malignant lesions was 96.9% (31/32) and morbidity was 1.5%. Consistent with other published series margins of the biopsy cylinder containing a malignant lesion were involved in 83.9% (26/31).
      Conclusions: Excisional biopsy using the ABBI system is a reliable diagnostic tool with a low incidence of morbidity. The therapeutic use is of limited potential.
    • Publication Date:
      Date Created: 20000714 Date Completed: 20000926 Latest Revision: 20191104
    • Publication Date:
      20231215
    • Accession Number:
      10.1024/1023-9332.6.3.111
    • Accession Number:
      10894011